News
The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...
Easy at-home tests for colon cancer, including FIT and Cologuard, offer alternatives to traditional colonoscopies for early ...
When It Comes to Colon Cancer Screening, Early Detection Is Key The Cologuard® test screens for the most preventable but least prevented cancer.
Exact Sciences reports strong Q1 2025 results with 11% revenue growth, boosted by Cologuard Plus and Oncodetect.
Colorectal Cancer Awareness Month is observed annually in March and aims to promote screening and early detection, raise awareness, and offer support to those battling the disease. As it has done ...
Cologuard Plus™ test raises the performance bar with sensitivities of 95% for colorectal cancer and 43% for advanced precancerous lesions at 94% specificity Cologuard Plus test will minimize ...
Colonoscopy is recommended for people over 45, but preparation turns off many. Here's a look at how it compares to stool tests FIT and Cologuard.
Cologuard does have a program to help people file an appeal if they get an unexpected bill for a follow-up colonoscopy.
The Cologuard can say that you have an abnormality when a colonoscopy would indicate normal. For 45% of people with a positive Cologuard test, no abnormalities will be found upon colonoscopy.
Yet another colorectal cancer (CRC) screening option is now available, but will Cologuard be more used than other noninvasive tests?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results